You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ezetimibe

Showing 26 - 50 of 112
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Russian Coronary Heart Disease <<Treat to Goal>> (Study P05464)

Completed
Has Results
  • Coronary Heart Disease
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia, CKD Stage 5, Chronic Kidney Disease Requiring Chronic Dialysis Trial in Rome (Evolocumab, Ezetimibe,

Recruiting
  • Hypercholesterolemia
  • +2 more
  • Rome, Italy
    Policlinico Casilino
Dec 13, 2020

Hyperlipidemia Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Hyperlipidemia
  • Evolocumab
  • +3 more
  • Birmingham, Alabama
  • +82 more
Nov 4, 2022

Non Alcoholic Steatohepatitis Trial in San Diego (Ezetimibe)

Completed
Has Results
  • Non Alcoholic Steatohepatitis
  • Ezetimibe
  • San Diego, California
    University of California, San Diego
Jul 1, 2020

Diabetes, Impaired Renal Function Trial in Stockholm (Ezetimibe)

Completed
  • Diabetes Mellitus
  • Impaired Renal Function
  • Ezetimibe
  • Stockholm, Sweden
    Department of Medicine, Clinical Pharmacology Unit, Karolinska U
Feb 25, 2021

Hyperlipidemias Trial in United States (Bempedoic Acid + Ezetimibe Fixed-Dose Combination, Bempedoic Acid, Ezetimibe)

Completed
Has Results
  • Hyperlipidemias
  • Bempedoic Acid + Ezetimibe Fixed-Dose Combination
  • +3 more
  • Ames, Iowa
  • +4 more
Mar 25, 2020

Hypercholesterolemia, Atherosclerosis, Statin Adverse Reaction Trial in Georgetown (Bempedoic acid, Ezetimibe, Placebo)

Completed
Has Results
  • Hypercholesterolemia
  • +2 more
  • Bempedoic acid
  • +2 more
  • Georgetown, Texas
    (unnamed)
Apr 24, 2020

Endothelial Dysfunction Trial (Ezetimibe)

Completed
Has Results
  • Endothelial Dysfunction
  • Ezetimibe
  • (no location specified)
Feb 11, 2020

Hypercholesterolemia Trial in Japan (Evolocumab, Ezetimibe, Placebo to Evolocumab)

Completed
Has Results
  • Hypercholesterolemia
  • Evolocumab
  • +3 more
  • Nagoya-shi, Aichi, Japan
  • +34 more
Oct 20, 2020

Sitosterolemia Trial in Winnipeg (Ezetimibe)

Completed
  • Sitosterolemia
  • Ezetimibe
  • Winnipeg, Manitoba, Canada
    Richardson Centre for Functional Foods and Nutraceuticals
Jan 29, 2020

Hyperlipidemia Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Hyperlipidemia
  • Evolocumab
  • +2 more
  • Anaheim, California
  • +41 more
Jan 4, 2021

Type 2 Diabetes Trial in Canada (Colesevelam, Ezetimibe)

Completed
  • Type 2 Diabetes Mellitus
  • Calgary, Alberta, Canada
  • +8 more
Nov 22, 2019

Peripheral Arterial Disease Trial in Houston (drug, behavioral, procedure)

Completed
Has Results
  • Peripheral Arterial Disease
  • Ezetimibe
  • +8 more
  • Houston, Texas
    Baylor College of Medicine
Jan 22, 2020

Hypercholesterolemia Trial in Worldwide (Alirocumab SAR236553 (REGN727), Atorvastatin, Simvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab SAR236553 (REGN727)
  • +11 more
  • Sao Paulo, Brazil
  • +9 more
Dec 2, 2020

Hyperlipidemia Trial in Worldwide (Evolocumab, Placebo to Evolocumab, Ezetimibe)

Completed
Has Results
  • Hyperlipidemia
  • Evolocumab
  • +3 more
  • Carmichael, California
  • +57 more
Jul 1, 2020

Hyperlipidemia Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Hyperlipidemia
  • Evolocumab
  • +2 more
  • Birmingham, Alabama
  • +57 more
Jan 4, 2021

Hyperlipidemia Trial in Worldwide (Evolocumab, Ezetimibe, Placebo to Evolocumab)

Completed
Has Results
  • Hyperlipidemia
  • Evolocumab
  • +6 more
  • Birmingham, Alabama
  • +243 more
Nov 4, 2022

Hypercholesterolaemia Trial in Worldwide (Alirocumab SAR236553 (REGN727), Rosuvastatin, Atorvastatin)

Active, not recruiting
  • Hypercholesterolaemia
  • Alirocumab SAR236553 (REGN727)
  • +12 more
  • Boca Raton, Florida
  • +45 more
Jan 12, 2022

Homozygous Familial Hypercholesterolemia Trial in Beijing (AK102, Statins, Ezetimibe)

Unknown status
  • Homozygous Familial Hypercholesterolemia
  • Beijing, Beijing, China
  • +1 more
Nov 17, 2019

Hypercholesterolemia Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Hypercholesterolemia
  • Evolocumab
  • +4 more
  • Birmingham, Alabama
  • +95 more
Jul 15, 2022

Hypercholesterolemia Trial in China, India, Thailand (Alirocumab, Placebo for alirocumab, ezetimibe)

Completed
Has Results
  • Hypercholesterolemia
  • Beijing, China
  • +61 more
Sep 9, 2019

Hypercholesterolemia Trial in Worldwide (Atorvastatin, Ezetimibe, Alirocumab)

Completed
Has Results
  • Hypercholesterolemia
  • Anaheim, California
  • +69 more
Jun 10, 2020

Hypercholesterolemia Trial in Worldwide (Alirocumab, Rosuvastatin, Ezetimibe)

Completed
Has Results
  • Hypercholesterolemia
  • Chandler, Arizona
  • +92 more
Mar 26, 2020

Hypercholesterolemia Trial in United States (ETC-1002, Ezetimibe)

Completed
  • Hypercholesterolemia
  • Birmingham, Alabama
  • +67 more
Mar 26, 2019

Hypercholesterolemia Trial in Worldwide (ALIROCUMAB SAR236553 (REGN727), (for injection training only), ezetimibe)

Completed
Has Results
  • Hypercholesterolemia
  • ALIROCUMAB SAR236553 (REGN727)
  • +5 more
  • Graz, Austria
  • +152 more
Mar 21, 2022